The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study

Publication date: Available online 7 May 2021Source: The Lancet Respiratory MedicineAuthor(s): P Jane McDowell, Sarah Diver, Freda Yang, Catherine Borg, John Busby, Vanessa Brown, Rahul Shrimanker, Ciara Cox, Christopher E Brightling, Rekha Chaudhuri, Ian D Pavord, Liam G Heaney, P Jane McDowell, Sarah Diver, Freda Yang, Catherine Borg, John Busby, Vanessa Brown, Rahul Shrimanker, Ciara Cox
Source: The Lancet Respiratory Medicine - Category: Respiratory Medicine Source Type: research